From: Identify glioma recurrence and treatment effects with triple-tracer PET/CT
Characteristics | Â | PET | ||
---|---|---|---|---|
N | NH3 | DOPA | FDG | |
N | 43 | 34 | 43 | 37 |
Gender | Â | Â | Â | Â |
Male | 27 | 20 | 27 | 23 |
Female | 16 | 14 | 16 | 14 |
Age (years) | 38.5 ± 6.37 | 40.38 ± 12.41 | 38.5 ± 6.37 | 40.28 ± 6.36 |
WHO grade | Â | Â | Â | Â |
II | 12 | 11 | 12 | 12 |
III | 15 | 10 | 15 | 11 |
IV | 16 | 13 | 16 | 14 |
IDH1 | Â | Â | Â | Â |
Mutation | 24 | 21 | 24 | 21 |
Wide type | 13 | 7 | 13 | 10 |
NA | 6 | 6 | 6 | 6 |
Final diagnosis | Â | Â | Â | Â |
TuR | 34 | 26 | 34 | 29 |
TrE | 9 | 8 | 9 | 8 |